EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine Alleviates 1-Methyl-3-Nitro-1-Nitrosoguanidine Induced Chronic Atrophic Gastritis in Rats

Lingling Wang, Liqun Xie

Turkish Journal of Gastroenterology · 2025

DOI: 10.5152/tjg.2025.24065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2025. Verfasst von Lingling Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Medical University, Jiangsu, China. Hauptthemen laut MEDLINE: Berberine, Gastritis, Atrophic. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Berberine (BBR), an isoquinoline alkaloid derived from Berberis plants, exhibits anti-inflammatory, anti-cancer, and antioxidant properties. This study explored the role of BBR in chronic atrophic gastritis (CAG). Materials and Methods: The 1-methyl-3-nitro-1-nitrosoguanidine and an irregular diet were used to establish the CAG model. Chronicatrophic gastritis rats were administered BBR at different doses via gavage, and teprenone (TEP) served as the positive control drug. We monitored and measured changes in body weight and food intake, pepsin activity, and gastric acid levels in the rats. Hematoxylin and eosin staining was utilized to scan the pathological condition in the gastric mucosal tissue of rats, while enzyme-linked immunosorbent assay was utilized to analyze alterations in serum inflammatory factors and hormone levels. Western blot was employed to evaluate protein expression. Additionally, 16S rRNA was conducted to assess changes in the intestinal flora of CAG rats.

Results

Berberine increased body weight and food intake, improved gastric atrophy, and enhanced pepsin activity and total acidity of gastric juice in CAG rats. BBR treatment led to decreased levels of inflammation factors and motilin, while gastrin and somatostatin levels were elevated in CAG rats. Additionally, BBR inhibited the NF-κB and MAPK pathway in these rats. Berberine treatment also regulated the composition and abundance of intestinal flora. These microbiome alterations suggest a possible role in modulating gut inflammation associated with CAG.

Conclusion

Berberine may alleviate CAG injury by reducing inflammation and regulating intestinal flora, which may be closely associ ated with the NF-κB and MAPK pathways. Cite this article as: Wang L, Xie L. Berberine alleviates 1-methyl-3-nitro-1 nitrosoguanidine-induced chronic atrophic gastritis in rats. Turk J Gastroenterol. 2025;36(11):723-731.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineGastritis, AtrophicAnimalsMethylnitronitrosoguanidineRatsMaleGastric MucosaDisease Models, AnimalRats, Sprague-DawleyChronic DiseaseGastrointestinal MicrobiomeEating

Stichwörter der Autor:innen

BerberineMAPKNF-κBchronic atrophic gastritisintestinal flora

Substanzen

BerberineMethylnitronitrosoguanidine

Autor:innen und Institutionen

  • Nanjing Medical University, Jiangsu, China.
  • The First Affiliated Hospital with Nanjing Medical University, Jiangsu, China.

Zitieren

APA

Wang, L., & Xie, L. (2025). Berberine Alleviates 1-Methyl-3-Nitro-1-Nitrosoguanidine Induced Chronic Atrophic Gastritis in Rats. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2025.24065

Vancouver

Wang L, Xie L. Berberine Alleviates 1-Methyl-3-Nitro-1-Nitrosoguanidine Induced Chronic Atrophic Gastritis in Rats. Turkish Journal of Gastroenterology. 2025. doi:10.5152/tjg.2025.24065

BibTeX
@article{Wang2025,
  author = {Wang, Lingling and Xie, Liqun},
  title = {Berberine Alleviates 1-Methyl-3-Nitro-1-Nitrosoguanidine Induced Chronic Atrophic Gastritis in Rats},
  journal = {Turkish Journal of Gastroenterology},
  year = {2025},
  doi = {10.5152/tjg.2025.24065}
}
Kostenlos starten →